Works matching IS 11738804 AND DT 2013 AND VI 27
Results: 58
Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 585, doi. 10.1007/s40259-013-0045-2
- By:
- Publication type:
- Article
Alpha-1 Antitrypsin Deficiency: New Developments in Augmentation and Other Therapies.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 547, doi. 10.1007/s40259-013-0042-5
- By:
- Publication type:
- Article
Sorafenib and Thyroid Cancer.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 615, doi. 10.1007/s40259-013-0049-y
- By:
- Publication type:
- Article
Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 591, doi. 10.1007/s40259-013-0048-z
- By:
- Publication type:
- Article
Therapeutic Potential of Targeting Interleukin 5 in Asthma.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 559, doi. 10.1007/s40259-013-0047-0
- By:
- Publication type:
- Article
Emerging Targets and Novel Approaches to Ebola Virus Prophylaxis and Treatment.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 565, doi. 10.1007/s40259-013-0046-1
- By:
- Publication type:
- Article
Acknowledgement to Referees.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 545, doi. 10.1007/s40259-013-0075-9
- Publication type:
- Article
Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells.
- Published in:
- BioDrugs, 2013, v. 27, n. 6, p. 605, doi. 10.1007/s40259-013-0050-5
- By:
- Publication type:
- Article
Cationic Host Defence Peptides: Potential as Antiviral Therapeutics.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 479, doi. 10.1007/s40259-013-0039-0
- By:
- Publication type:
- Article
Lixisenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 509, doi. 10.1007/s40259-013-0057-y
- By:
- Publication type:
- Article
Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 525, doi. 10.1007/s40259-013-0061-2
- By:
- Publication type:
- Article
Genome-Based Bacterial Vaccines: Current State and Future Outlook.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 419, doi. 10.1007/s40259-013-0034-5
- By:
- Publication type:
- Article
The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 431, doi. 10.1007/s40259-013-0040-7
- By:
- Publication type:
- Article
Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 469, doi. 10.1007/s40259-013-0038-1
- By:
- Publication type:
- Article
A Review of Dendritic Cell Therapy for Cancer: Progress and Challenges.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 453, doi. 10.1007/s40259-013-0030-9
- By:
- Publication type:
- Article
Erratum to: Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane.
- Published in:
- 2013
- By:
- Publication type:
- Erratum
Pegylated Liposomal Doxorubicin: A Guide to Its Use in Various Malignancies.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 533, doi. 10.1007/s40259-013-0070-1
- By:
- Publication type:
- Article
Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 495, doi. 10.1007/s40259-013-0036-3
- By:
- Publication type:
- Article
The Th17 Pathway as a Therapeutic Target in Rheumatoid Arthritis and Other Autoimmune and Inflammatory Disorders.
- Published in:
- BioDrugs, 2013, v. 27, n. 5, p. 439, doi. 10.1007/s40259-013-0035-4
- By:
- Publication type:
- Article
Managing Unexpected Events in the Manufacturing of Biologic Medicines.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 305, doi. 10.1007/s40259-013-0018-5
- By:
- Publication type:
- Article
Biological Therapies for Rheumatoid Arthritis: Progress to Date.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 329, doi. 10.1007/s40259-013-0021-x
- By:
- Publication type:
- Article
Asparaginase Erwinia chrysanthemi (Erwinaze): A Guide to Its Use in Acute Lymphoblastic Leukemia in the USA.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 413, doi. 10.1007/s40259-013-0051-4
- By:
- Publication type:
- Article
Immune Globulin (Human) 10 % Liquid: A Review of its Use in Primary Immunodeficiency Disorders.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 393, doi. 10.1007/s40259-013-0044-3
- By:
- Publication type:
- Article
Bevacizumab Combination Therapy: A Review of its Use in Patients with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 375, doi. 10.1007/s40259-013-0043-4
- By:
- Publication type:
- Article
Everolimus: A Guide to Its Use in Liver Transplantation.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 407, doi. 10.1007/s40259-013-0041-6
- By:
- Publication type:
- Article
TNF Inhibition for Ophthalmic Indications: Current Status and Outlook.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 347, doi. 10.1007/s40259-013-0022-9
- By:
- Publication type:
- Article
Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 293, doi. 10.1007/s40259-013-0016-7
- By:
- Publication type:
- Article
RNA Interference in the Treatment of Colon Cancer.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 317, doi. 10.1007/s40259-013-0019-4
- By:
- Publication type:
- Article
Therapeutic Potential of Regulatory T cells in Autoimmune Disorders.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 281, doi. 10.1007/s40259-013-0026-5
- By:
- Publication type:
- Article
Therapeutic Strategies in Psoriasis Patients with Psoriatic Arthritis: Focus on New Agents.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 359, doi. 10.1007/s40259-013-0025-6
- By:
- Publication type:
- Article
Canakinumab: A Guide to Its Use in Acute Gouty Arthritis Flares.
- Published in:
- BioDrugs, 2013, v. 27, n. 4, p. 401, doi. 10.1007/s40259-013-0037-2
- By:
- Publication type:
- Article
Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero): A Review of its Use in Primary and Booster Vaccination.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 263, doi. 10.1007/s40259-013-0029-2
- By:
- Publication type:
- Article
Regorafenib for Gastrointestinal Malignancies.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 213, doi. 10.1007/s40259-013-0014-9
- By:
- Publication type:
- Article
Gene Therapy for Fabry Disease: A Review of the Literature.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 237, doi. 10.1007/s40259-013-0032-7
- By:
- Publication type:
- Article
CD6 as a Therapeutic Target in Autoimmune Diseases: Successes and Challenges.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 191, doi. 10.1007/s40259-013-0027-4
- By:
- Publication type:
- Article
Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 275, doi. 10.1007/s40259-013-0024-7
- By:
- Publication type:
- Article
Belimumab Therapy in Systemic Lupus Erythematosus.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 225, doi. 10.1007/s40259-013-0031-8
- By:
- Publication type:
- Article
The Outlook for Alemtuzumab in Multiple Sclerosis.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 181, doi. 10.1007/s40259-013-0028-3
- By:
- Publication type:
- Article
Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 247, doi. 10.1007/s40259-013-0033-6
- By:
- Publication type:
- Article
Stem Cell Therapy in Osteoarthritis: A Step Too Far?
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 175, doi. 10.1007/s40259-013-0017-6
- By:
- Publication type:
- Article
Development and Regulation of Biosimilars: Current Status and Future Challenges.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 203, doi. 10.1007/s40259-013-0020-y
- By:
- Publication type:
- Article
B-Cell Targeted Therapies in Systemic Lupus Erythematosus.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 85, doi. 10.1007/s40259-013-0015-8
- By:
- Publication type:
- Article
A Novel Approach to Improve the Function of FGF21.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 159, doi. 10.1007/s40259-013-0013-x
- By:
- Publication type:
- Article
Differences Between Post-Authorization Adverse Drug Reactions of Biopharmaceuticals and Small Molecules.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 167, doi. 10.1007/s40259-013-0012-y
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Properties of a New Long-Acting Granulocyte Colony-Stimulating Factor (HM10460A) in Healthy Volunteers.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 149, doi. 10.1007/s40259-013-0010-0
- By:
- Publication type:
- Article
Platelet-Rich Plasma to Improve the Bio-Functionality of Biomaterials.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 97, doi. 10.1007/s40259-012-0004-3
- By:
- Publication type:
- Article
Immunotherapy of Multiple Sclerosis.
- Published in:
- BioDrugs, 2013, v. 27, n. 2, p. 113, doi. 10.1007/s40259-013-0011-z
- By:
- Publication type:
- Article
Targeting the B7 Family of Co-Stimulatory Molecules.
- Published in:
- BioDrugs, 2013, v. 27, n. 1, p. 1, doi. 10.1007/s40259-012-0001-6
- By:
- Publication type:
- Article
Vincristine Sulfate Liposome Injection.
- Published in:
- BioDrugs, 2013, v. 27, n. 1, p. 69, doi. 10.1007/s40259-012-0002-5
- By:
- Publication type:
- Article
Targeting Focal Adhesion Kinase in Fibrotic Diseases.
- Published in:
- BioDrugs, 2013, v. 27, n. 1, p. 15, doi. 10.1007/s40259-012-0003-4
- By:
- Publication type:
- Article